Vitaflo Acquires Mevalia and ComidaMed

Vitaflo International Ltd., a subsidiary of Nestlé Health Science, expanded its product offerings by acquiring the Dr. Schär brands, specifically Mevalia and ComidaMed. This acquisition was aimed at enhancing Vitaflo's existing portfolio that focuses on dietary management for individuals with Inborn Errors of Metabolism (IEM) and those with cow's milk protein allergies. The Dr. Schär brands are recognized for their specialized products that cater to these dietary needs, thereby allowing Vitaflo to provide a more comprehensive range of solutions for patients requiring specialized nutrition. The integration of these brands into Vitaflo's operations is expected to strengthen its market position in the field of medical nutrition, particularly in the management of IEM, which affects a significant number of individuals globally. By adding Mevalia and ComidaMed to its lineup, Vitaflo aims to address the growing demand for effective dietary management solutions in this niche market.